Vol 81, No 11 (2023)
Editorial
Published online: 2023-11-08

open access

Page views 434
Article views/downloads 403
Get Citation

Connect on Social Media

Connect on Social Media

Arterial tortuosity index, a promising imaging marker for early detection of Loeys-Dietz syndrome

Guglielmina Pepe1, Elisabetta Mariucci2, Stefano Nistri3
Pubmed: 37997841
Kardiol Pol 2023;81(11):1067-1068.

Abstract

Not available

EDITORIAL

Arterial tortuosity index, a promising imaging marker for early detection of Loeys-Dietz syndrome

Guglielmina Pepe1Elisabetta Mariucci2Stefano Nistri3
1Heritable Thoracic Aortic Aneurysm/Dissection & Heritable Rare Connective Tissue Diseases Service Villa Donatello, Sesto Fiorentino, Italy
2Marfan and Heritable Thoracic Aortic Disease Clinic, Bologna Hospital, Bologna, Italy
3Cardiology Service CMSR Veneto Medica, Altavilla Vicentina, Italy

Related article

by Chmielewski et al.

Correspondence to:

Prof. Guglielmina Pepe, MD, PhD,

Heritable Thoracic Aortic Aneurysm/Dissection

& Heritable Rare Connective Tissue Diseases Service Villa Donatello,

Via Attilio Ragionieri 101, 50019 Sesto Fiorentino FI, Italy

phone: +39 339 844 36 87

e-mail: guglielminapepe@hotmail.it

Copyright by the Author(s), 2023

DOI: 10.33963/v.kp.98163

Received: November 7, 2023

Accepted: November 7, 2023

Early publication date: November 8, 2023

Loeys-Dietz syndrome (LDS) displays 5 types that should be considered in differential diagnosis from Marfan syndrome (MFS) and other heritable rare connective tissue diseases (CTDs). The hallmarks of LDS are vascular disease extended beyond the aortic root, arterial tortuosity, hypertelorism, cleft palate, and bifid uvula [1, 2]. The genes associated with LDS types, all of which belong to the TGFbeta signaling, are as follows: LDS1/TGFBR1, LDS2/TGFBR2 are the most severe, LDS3/SMAD3, LDS4/TGFB2 are the most clinically similar to MFS, and LDS5/TGFB3 are the mildest [3, 4]. Since untreated Heritable Thoracic Aortic Diseases (HTAD) present a poor prognosis, early diagnosis and appropriate treatment are crucial. The article by Chmielewski et al. [5], reports on 34 patients with LDS (15 index cases, 19 relatives) undergoing clinical and molecular characterization [5]. This article raises multiple interesting considerations.

Importantly, the authors performed, for the first time, a quantitative analysis of the tortuosity of both cervical vessels and thoracic aorta in LDS patients detecting its presence in 100% and 68% of patients, respectively. These results underline and support [6, 7] the importance of quantitative tortuosity analysis of cervical and aortic arteries in LDS to investigate the potential of these clinical markers in early detection of LDSs and in their differential diagnosis from other CTDs. Indeed, increased carotid tortuosity is a known marker of disease severity associated with earlier aortic root replacement [6]. Moreover, the quantitative tortuosity index of intracranial (carotid and vertebral) arteries is higher in LDS compared to MFS, which may become another vascular differential diagnostic marker between the two diseases [7].

Aortic involvement was prevalent in this study as assessed by two different methods at the aortic root and the proximal ascending aorta. Two calculators are available now to detect aortic dilatation at each aortic level on a very wide age range. Campens et al. [8] provide upper limits of normal thoracic aorta and Z-score equations, while Frasconi et al. [9] provide a novel tool built by a machine learning technique. This novel Q-score can also capture the joint distribution of these variables with all four diameters simultaneously, thus accounting for the overall aortic shape. Sixteen (47%) patients in the study by Chmielewski et al. [5] suffered from their first aortic event (9 A-type AD, 6 elective thoracic aortic surgeries, and one sudden death) at a median age of 35 years. Notably, second and third aortic events occurred in 9 and 4 patients, respectively, underscoring the need for lifelong surveillance in patients after thoracic aortic surgery, particularly in cases of dissection and genetic conditions [10].

In Table S3, the authors report the absence of aortic or cardiovascular events in 5 TGFB2 patients while only 2 patients turned out to carry pathogenic mutations in the gene (Table S1 & Results). It would be useful to know these 2 patients’ sex, age, and aortic diameters to understand if the absence of aortic and cardiovascular events is justified.

In the Results section, the authors report that 6 LDS cases met the diagnostic criteria for MFS also because they had a score of 7/>7 for systemic features. If these patients have mutations in one of the 4 reported genes (TGFB2, TGFBR1&2, SMAD3), they have LDS. There are not enough details about all the systemic manifestations in each patient and the exact localization of the ectasia or aneurysm of the aorta. A precise size of diameters in each of the patients is necessary for clinical diagnosis.

The authors underline in the Discussion considerable variability in the intrafamilial clinical features. It is important to clarify that this correct observation is common among hereditary pathologies. In syndromic aneurysms, it is certainly easier to notice it because of the pleiotropism of these pathologies. Rather, the bicuspid aortic valve (BAV) is a hereditary pathology with autosomal dominant transmission but with incomplete penetrance [11]; for this reason, it can even be absent in one generation and reappear in the next one. Moreover, through generations, patients may display isolated BAV and/or thoracic aneurysm or associated BAV/thoracic aneurysm.

In conclusion, the results of the study by Chmielewski and colleagues underline the importance of quantitative tortuosity analysis of cervical and aortic arteries in LDSs and the potential use of these clinical markers in early detection of LDSs and differential diagnosis from other CTDs. At this point, if quantitative tortuosity is a marker that can refine the working diagnosis and accelerate the differential diagnosis process, subsequent studies will have to confirm this but also elucidate whether the absence of tortuosity has a negative predictive value.

Article information

Conflict of interest: None declared.

Funding: None.

Open access: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, which allows downloading and sharing articles with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. For commercial use, please contact the journal office at kardiologiapolska@ptkardio.pl.

REFERENCES

  1. Caruana M, Baars MJ, Bashiardes E, et al. HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERN. Eur J Med Genet. 2023; 66(1): 104673, doi: 10.1016/j.ejmg.2022.104673, indexed in Pubmed: 36460281.
  2. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010; 47(7): 476485, doi: 10.1136/jmg.2009.072785, indexed in Pubmed: 20591885.
  3. De Cario R, Giannini M, Cassioli G, et al. Tracking an elusive killer: state of the art of molecular-genetic knowledge and laboratory role in diagnosis and risk stratification of thoracic aortic aneurysm and dissection. Diagnostics (Basel). 2022; 12(8): 1785, doi: 10.3390/diagnostics12081785, indexed in Pubmed: 35892496.
  4. Nistri S, De Cario R, Sticchi E, et al. Differential diagnosis between marfan syndrome and loeys-dietz syndrome type 4: a novel chromosomal deletion covering TGFB2. Genes (Basel). 2021; 12(10): 1462, doi: 10.3390/genes12101462, indexed in Pubmed: 34680857.
  5. Chmielewski P, Ponińska JK, Michalak E, et al. Cardiovascular involvement and prognosis in Loeys-Dietz syndrome. Kardiol Pol. 2023; 81(11): 10961102, doi: 10.33963/v.kp.97390, indexed in Pubmed: 37823753.
  6. Chu LC, Haroun RR, Beaulieu RJ, et al. Carotid artery tortuosity index is associated with the need for early aortic root replacement in patients with Loeys-Dietz syndrome. J Comput Assist Tomogr. 2018; 42(5): 747753, doi: 10.1097/RCT.0000000000000764, indexed in Pubmed: 29901510.
  7. Spinardi L, Vornetti G, De Martino S, et al. Intracranial arterial tortuosity in marfan syndrome and loeys-dietz syndrome: tortuosity index evaluation is useful in the differential diagnosis. AJNR Am J Neuroradiol. 2020; 41(10): 19161922, doi: 10.3174/ajnr.A6732, indexed in Pubmed: 32819908.
  8. Campens L, Demulier L, De Groote K, et al. Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. Am J Cardiol. 2014; 114(6): 914920, doi: 10.1016/j.amjcard.2014.06.024, indexed in Pubmed: 25092193.
  9. Frasconi P, Baracchi D, Giusti B, et al. Two-Dimensional aortic size normalcy: a novelty detection approach. Diagnostics (Basel). 2021; 11(2): 220, doi: 10.3390/diagnostics11020220, indexed in Pubmed: 33540834.
  10. Fleischmann D, Afifi RO, Casanegra AI, et al. Imaging and surveillance of chronic aortic dissection: a scientific statement from the American Heart Association. Circ Cardiovasc Imaging. 2022; 15(3): e000075, doi: 10.1161/HCI.0000000000000075, indexed in Pubmed: 35172599.
  11. Prakash SK, Bossé Y, Muehlschlegel JD, et al. A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium). J Am Coll Cardiol. 2014; 64(8): 832839, doi: 10.1016/j.jacc.2014.04.073, indexed in Pubmed: 25145529.